Harrow (HROW) FCF Margin (QoQ) (2013 - 2026)
Harrow (HROW) FCF Margin (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.34 Bn | 43.38 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.87 Bn | 40.22 Bn | 2.15 Bn |
| 3 | Zoetis | 32.46 Bn | 30.78 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.97 Bn | 18.08 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.94 Bn | 11.41 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - |
| 10 | Harrow | 1.56 Bn | 1.48 Bn | 50.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 628.00 |
| Mar 31, 2026 | -2,984.00 |
| Dec 31, 2025 | -1,352.00 |
| Sep 30, 2025 | 2,377.00 |
| Jun 30, 2025 | -4,196.00 |
| Mar 31, 2025 | 6,949.00 |
| Dec 31, 2024 | -3,445.00 |
| Sep 30, 2024 | 1,124.00 |
| Jun 30, 2024 | 812.00 |
| Mar 31, 2024 | -3,702.00 |
| Dec 31, 2023 | 3,027.00 |
| Sep 30, 2023 | -2,166.00 |
| Jun 30, 2023 | 4,815.00 |
| Mar 31, 2023 | -1,079.00 |
| Dec 31, 2022 | -1,616.00 |
| Sep 30, 2022 | -2,614.00 |
| Jun 30, 2022 | 1,718.00 |
| Mar 31, 2022 | 1,060.00 |
| Dec 31, 2021 | 458.00 |
| Sep 30, 2021 | -3,630.00 |